Physician profile
Jerry D Young
NPI 1154408235
$566.16
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $33.92 · 2021: $61.99 · 2023: $195 · 2024: $55.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $155.16 | 2019-2023 | Abthera Advance |
| Smith+Nephew, INC. | $88.95 | 2019-2021 | |
| Covidien LP | $62.30 | 2019 | |
| Ets Wound Care LLC | $58.38 | 2023 | |
| Heron Therapeutics, INC. | $46.19 | 2023 | Zynrelef |
| Acera Surgical, INC. | $29.66 | 2024 | Restrata Wound Matrix |
| Nevro Corp. | $25.47 | 2024 | Senza |
| Abbvie INC. | $19.16 | 2021 | |
| Tactile Systems Technology INC | $18.32 | 2020 | |
| Kerecis Limited | $17.61 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $15.60 | 2020 | |
| Olympus America INC. | $14.99 | 2019 | |
| Stryker Corporation | $14.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.